No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HQY HealthEquity
- 80.380
- +1.110+1.40%
Close May 7 16:00 ET
- 79.220
- -1.160-1.44%
Post 16:24 ET
6.93BMarket Cap125.59P/E (TTM)
80.775High78.980Low670.27KVolume79.630Open79.270Pre Close53.81MTurnover0.79%Turnover Ratio125.59P/E (Static)86.16MShares84.49052wk High3.40P/B6.79BFloat Cap54.09052wk Low--Dividend TTM84.49MShs Float101.580Historical High--Div YieldTTM2.26%Amplitude15.800Historical Low80.288Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
HealthEquity Sets Date to Announce First Quarter Results
Presentation at ConferencesDRAPER, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") cust
Healthequity (HQY): A Strong Buy on Digital Wallet Expansion and Enhanced Profitability
20 Fastest Growing Fintech Companies In 2024
Team Member Feedback Earns HealthEquity Workplace Culture Recognition
DRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY), the nation's largest Health Savings Account (HSA) custodian has received a Culture Excellence Award by Top Workplaces for the fourth
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Cellectis SA (CLLS) and Idexx Laboratories (IDXX)
Express News | HealthEquity Inc - Board Has Reduced Size of Board to 10 Members Effective Immediately Following 2024 Annual Meeting of Stockholders
Comments
HealthEquity's high P/S ratio could possibly be due to market expectations for future growth. The current justification for the high ratio lies on the low chance of decreased revenues, which investors expect to uphold share price.
Despite expenses reducing earnings last year, HealthEquity's future outlook remains positive. Unusual items don't typically recur, suggesting underestimated earning potential. The firm returned to profitability this year.
Despite HealthEquity's revenue growth and share price rise over three years, short-term underperformance and negative five-year returns are concerning. Fundamental improvements are required for shareholder confidence. Analyst forecasts could shed light on the company's future.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg